跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TAPENTADOL RETARD ZENTIVA 150 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TAPENTADOL RETARD ZENTIVA 150 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG
Approved
STANDARD
TAPENTADOL RETARD ZENTIVA 150 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG
Zentiva K.S.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 20, 2023
Approval ID
1269f7ff36ff3d63
Company
Zentiva K.S.
Type
Standard
Approval Details
Approval Id
1269f7ff36ff3d63
Drug Cima Aemps Name
TAPENTADOL RETARD ZENTIVA 150 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG
Register Number
88283
Holder Company Name
Zentiva K.S.
Marketing Company Name
Zentiva Spain S.L.
Holder Company Detail Path
/organization/zentiva-k-s
Authorization Date
2023-04-20
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
150 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Estupefacientes
Commercialized
No
Company Name
Zentiva K.S.
Company Detail Path
/organization/zentiva-k-s
Company Information
Pharmaceutical Company Name
Zentiva, k.s.
Country Name
Czech Republic
City Name
praha,hlavní město praha,country_cz
Address
U kabelovny 130/22
Active Ingredients
TAPENTADOL FOSFATO
229,709 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 20, 2023
Approval ID
1269f7ff36ff3d63
Type
Standard
Back to CIMA-AEMPS Approvals